Edesa Biotech, Inc.
EDSA
$4.72
-$0.01-0.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -209.09% | -165.24% | -38.98% | -131.62% | -4.87% |
| Total Depreciation and Amortization | -0.78% | 5.71% | -40.84% | -41.40% | -49.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 208.62% | 626.99% | 392.49% | 330.67% | 62.01% |
| Change in Net Operating Assets | 1,233.85% | 291.29% | -995.04% | 153.88% | -123.74% |
| Cash from Operations | -81.25% | 15.39% | -37.58% | -77.97% | -98.58% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 458.04% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 97.94% | -48.33% | -8.28% | 100.00% |
| Cash from Financing | -- | -100.06% | 61.98% | 693.95% | -100.00% |
| Foreign Exchange rate Adjustments | -121.35% | 60.11% | 69.86% | -586.27% | 2,097.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.42% | -116.61% | 139.38% | -56.39% | -102.32% |